Navigation Links
Cholera and vaccine experts urge United States to stockpile vaccine
Date:11/24/2010

As the cholera epidemic in Haiti continues to rage, public health workers are focusing their efforts on treating the tens of thousands who have already been hospitalized with cholera-like symptoms and providing clean water and adequate sanitation to control the disease's spread.

Could the United States be doing more to help the situation? In an editorial published in the November 24, 2010, issue of the New England Journal of Medicine, vaccine and infectious disease specialists Matthew Waldor of the Howard Hughes Medical Institute, Peter Hotez of George Washington University and the Sabin Vaccine Institute, and John Clemens of the International Vaccine Institute in Korea note that safe and reasonably effective vaccines are available that could complement these efforts. These vaccines are in short supply, however, and the scientists state that the United States should stockpile cholera vaccines for rapid deployment to parts of the world that become at high-risk for the disease.

"The resistance to vaccination is truly baffling," says Waldor, a microbiologist and infectious disease specialist whose laboratory at Brigham and Women's Hospital studies cholera and other pathogenic bacteria that infect the gut. "The point of view [regarding controlling cholera in Haiti] has been that effort should be made toward establishing field hospitals to provide life-saving rehydration therapy. I totally understand that. However, I think it's a false dichotomy to say we can only do one or the other."

The World Health Organization estimates that three to five million people develop cholera each year. Untreated, the disease, which causes severe diarrhea and extreme dehydration, can kill within hours. It is most prevalent in areas where basic infrastructure, clean water, and sanitation are not available. Although the disease is usually treatable by replacing lost fluids, such interventions can be difficult to administer in regions that lack adequate medical faci
'/>"/>

Contact: Jennifer Michalowski
michalow@hhmi.org
301-215-8576
Howard Hughes Medical Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. From cholera to blindness, experts present cutting-edge research at international meeting
2. Dartmouth study uses the patients tumor to form vaccine
3. Medicare Panel Endorses Vaccine for Prostate Cancer Patients
4. Few Young Women Getting Cervical Cancer Vaccine
5. Few eligible young women choose to take HPV vaccine to prevent cervical cancer, study shows
6. Breakthrough in cancer vaccine research
7. U of M researcher finds public support for HPV vaccine wanes when linked to controversy
8. New Polio Vaccine Shows Major Advantages: Study
9. Egg allergy: Not a reason to avoid flu vaccine after all
10. UT Southwestern researchers create experimental vaccine against Alzheimers
11. NIH funds advanced development of 3 biodefense vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... coffee is associated with a reduced risk of ... Mayo Clinic research shows. The findings were being ... in Orlando, Fla. , PSC is an ... in inflammation and subsequent fibrosis that can lead ... biliary cancer. , "While rare, PSC has extremely ...
(Date:5/18/2013)... Utah (PRWEB) May 18, 2013 ... on insurance agents’ role in Marketplaces . ... to traditional employer sponsored health benefits, is the ... and health reimbursement arrangements . , ... Health and Human Services (HHS) recently released a ...
(Date:5/18/2013)... The “World Healthcare IT Market: Trends & Forecast ... drivers, restraints, and opportunities in North America, Europe, Asia, ... 89 market data tables , ... Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early ... global healthcare IT market is expected to grow from ...
(Date:5/18/2013)... York, New York (PRWEB) May 18, 2013 ... to mount in courts throughout the country, Bernstein Liebhard ... metal-on-metal hip replacement patients often suffer tissue damage before ... the study, which according to Science Daily will appear ... metal-on-metal hip replacement recipients underwent MRI screens of their ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices Market ... (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, ... the major market drivers, restraints, and opportunities in North ... Browse , 147 market data ... 318 pagesand in-depth TOC of “Sleep ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3
... ten years since dolly’s birth and scientist are still doing ... ,Dolly offered hope to millions of sick and disabled people ... the world's first clone of an adult mammal. From then ... advanced and the cloning technique has been refined. Cloning is ...
... protein named menin – involved in tumor-suppression or cell-proliferation-suppressing ... which again affected blood sugar// regulation - researchers at ... ,In humans menin gene (Men1) mutation can lead ... 1 (MEN1) and this discovery also has implications for ...
... of oral clefting leaves some with psychological problems into adulthood. ... quality of life can be used to learn about the ... ,Oral clefting is one of the most common ... and can vary by age and type of clefting. Children ...
... Antibiotics - decreased cell death and heart attack injury ... cells//. ,A study with rapamycin - an ... by Virginia Commonwealth University researchers have revealed that heart ... protected by rapamycin. ,In the July issue ...
... botox – an anti-wrinkle treatment, Dr Frederic Meunier, ... a cure for motoneuronal diseases//. ,Researcher ... system in the body, which blocked the unnecessary ... motorneuron diseases. ,Motoneuronal diseases cause a ...
... stomach cancer who receive chemotherapy before and after surgery have ... published in Thursday‘s the 5th of July, New England Journal ... of death by at least a quarter, when compared to ... shrinking the tumors and thereby improved the survival without a ...
Cached Medicine News:Health News:Dolly Paves the Way for Exhaustive Stem Cell Research 2Health News:Menin Gene Mutation made Insulin Secreting Cells to Proliferate 2Health News:Learning the Value of Prevention and Treatment in Oral Clefting 2Health News:Antibiotic Proved Protective against Heart Tissue Damage and Cell Death – Research Find 2
(Date:5/16/2013)... 2013  PTC Therapeutics, Inc., today announced that it ... the U.S. Securities and Exchange Commission ("SEC") relating to ... The number of shares to be offered and the ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... book-running managers for the offering. Cowen and Company is ...
(Date:5/16/2013)... and SYDNEY , May 16, ... - ASX: HIN), a leading innovator of less invasive, miniaturized ... heart failure, today announced that CEO Doug Godshall ... Global Healthcare Conference at 11:00 a.m. EDT on Monday, May ... at the Sheraton New York Hotel. A live ...
(Date:5/16/2013)... , May 16, 2013 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the treatment ... Richard King , President and CEO, will present a ... Sheraton New York Hotel in New York ... 2013 at 9:30 a.m. ET/6:30 a.m. PT. The ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3
... wishes to correct and clarify its news release issued on March ... any implications about NIOSH approval, specifically:, , ... of the Avon Rubber group, received the NIOSH approvals for the ... , The ST53 SCBA system ...
... Test of prototype 3D display exceeds performance expectations.LIVONIA, Mich., April ... three Oakwood Heritage Hospital surgeons and their medical support team ... cadaver to test the new LifeVision(TM) family of 3D technologies ... This event marks the first time in history ...
Cached Medicine Technology:Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 2Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 3Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 4
... well as humidification, try Flo-Mist™., ,Flo-Mist™, ... continuous medication nebulizer (CMN), engineered to deliver ... ml reservoir and jet flow design allow ... medication delivery at 25 ml/hr. Particles are ...
Nebulizer Custom Kit...
... Innovators in Anesthesia and Respiratory Products, ... quality medical devices for Anesthesia and Respiratory ... manufacture products that enhance the clinician's ability ... close attention to the bottom line. , ...
... nebulizer achieves optimum lung penetration for maximum ... is 1.04-1.10 µ at 6-8 LPM. Latex-free ... ,As the world leader in airway ... assurance of proven technology by offering top ...
Medicine Products: